[1]
“Synthesis and molecular docking of isonicotinohydrazide derivatives as anti-tuberculosis candidates”, Mal. J. Fund. Appl. Sci., vol. 15, no. 3, pp. 367–371, Jun. 2019, doi: 10.11113/mjfas.v15n3.1030.